
Farley J. Abad
Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2181 |
| Total Applications | 1076 |
| Issued Applications | 864 |
| Pending Applications | 101 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 564330
[patent_doc_number] => 07465574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-16
[patent_title] => 'Recombinant RSV virus expression systems and vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/078900
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 20713
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/465/07465574.pdf
[firstpage_image] =>[orig_patent_app_number] => 11078900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/078900 | Recombinant RSV virus expression systems and vaccines | Mar 10, 2005 | Issued |
Array
(
[id] => 7038906
[patent_doc_number] => 20050158340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Recombinant RSV virus expression systems and vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/079002
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20477
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158340.pdf
[firstpage_image] =>[orig_patent_app_number] => 11079002
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/079002 | Recombinant RSV virus expression systems and vaccines | Mar 10, 2005 | Abandoned |
Array
(
[id] => 202969
[patent_doc_number] => 07632923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-15
[patent_title] => 'Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/074803
[patent_app_country] => US
[patent_app_date] => 2005-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 34
[patent_no_of_words] => 32944
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/632/07632923.pdf
[firstpage_image] =>[orig_patent_app_number] => 11074803
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/074803 | Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof | Mar 8, 2005 | Issued |
Array
(
[id] => 813368
[patent_doc_number] => 07413741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-19
[patent_title] => 'HCV E1 comprising specific disulfide bridges'
[patent_app_type] => utility
[patent_app_number] => 11/073942
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17689
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/413/07413741.pdf
[firstpage_image] =>[orig_patent_app_number] => 11073942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/073942 | HCV E1 comprising specific disulfide bridges | Mar 7, 2005 | Issued |
Array
(
[id] => 5774678
[patent_doc_number] => 20050268353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Insect viruses and their uses in protecting plants'
[patent_app_type] => utility
[patent_app_number] => 11/075046
[patent_app_country] => US
[patent_app_date] => 2005-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 56
[patent_no_of_words] => 35097
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20050268353.pdf
[firstpage_image] =>[orig_patent_app_number] => 11075046
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/075046 | Insect viruses and their uses in protecting plants | Mar 6, 2005 | Abandoned |
Array
(
[id] => 4886446
[patent_doc_number] => 20080260778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Method of Vaccination Against Testicular Bvdv Infection'
[patent_app_type] => utility
[patent_app_number] => 10/593134
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8231
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260778.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593134
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593134 | Method of Vaccination Against Testicular Bvdv Infection | Mar 3, 2005 | Abandoned |
Array
(
[id] => 439139
[patent_doc_number] => 07258992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-21
[patent_title] => 'Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection'
[patent_app_type] => utility
[patent_app_number] => 11/066594
[patent_app_country] => US
[patent_app_date] => 2005-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 18100
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/258/07258992.pdf
[firstpage_image] =>[orig_patent_app_number] => 11066594
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/066594 | Immunization of dairy cattle with chimeric GapC protein against Streptococcus infection | Feb 24, 2005 | Issued |
Array
(
[id] => 6930808
[patent_doc_number] => 20050281843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Use of bioadhesives and adjuvants for the mucosal delivery of antigens'
[patent_app_type] => utility
[patent_app_number] => 11/066120
[patent_app_country] => US
[patent_app_date] => 2005-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8060
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281843.pdf
[firstpage_image] =>[orig_patent_app_number] => 11066120
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/066120 | Use of bioadhesives and adjuvants for the mucosal delivery of antigens | Feb 24, 2005 | Abandoned |
Array
(
[id] => 173724
[patent_doc_number] => 07659103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle'
[patent_app_type] => utility
[patent_app_number] => 10/589902
[patent_app_country] => US
[patent_app_date] => 2005-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15063
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/659/07659103.pdf
[firstpage_image] =>[orig_patent_app_number] => 10589902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/589902 | Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle | Feb 20, 2005 | Issued |
Array
(
[id] => 7074319
[patent_doc_number] => 20050147587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'G-CSF conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/053228
[patent_app_country] => US
[patent_app_date] => 2005-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 35610
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20050147587.pdf
[firstpage_image] =>[orig_patent_app_number] => 11053228
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/053228 | G-CSF conjugates | Feb 7, 2005 | Abandoned |
Array
(
[id] => 7227853
[patent_doc_number] => 20050255460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Methods of diagnosing cervical cancer'
[patent_app_type] => utility
[patent_app_number] => 11/053076
[patent_app_country] => US
[patent_app_date] => 2005-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 43825
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255460.pdf
[firstpage_image] =>[orig_patent_app_number] => 11053076
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/053076 | Methods of diagnosing cervical cancer | Feb 6, 2005 | Abandoned |
Array
(
[id] => 173551
[patent_doc_number] => 07658930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Kit for detecting the antibody of HCV and its preparing method'
[patent_app_type] => utility
[patent_app_number] => 11/883506
[patent_app_country] => US
[patent_app_date] => 2005-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 15224
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/658/07658930.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883506
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883506 | Kit for detecting the antibody of HCV and its preparing method | Feb 1, 2005 | Issued |
Array
(
[id] => 167233
[patent_doc_number] => 07666420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Composition for treating pathology associated with MSRV/HERV-W'
[patent_app_type] => utility
[patent_app_number] => 10/586742
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 30
[patent_no_of_words] => 27971
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/666/07666420.pdf
[firstpage_image] =>[orig_patent_app_number] => 10586742
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/586742 | Composition for treating pathology associated with MSRV/HERV-W | Jan 23, 2005 | Issued |
Array
(
[id] => 5023795
[patent_doc_number] => 20070149761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Hcv rna dependent rna polymerase'
[patent_app_type] => utility
[patent_app_number] => 10/584810
[patent_app_country] => US
[patent_app_date] => 2005-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4470
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149761.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584810
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584810 | HCV RNA-dependent RNA polymerase | Jan 5, 2005 | Issued |
Array
(
[id] => 7169442
[patent_doc_number] => 20050202418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'HCV peptide compositions'
[patent_app_type] => utility
[patent_app_number] => 11/023183
[patent_app_country] => US
[patent_app_date] => 2004-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 166
[patent_figures_cnt] => 166
[patent_no_of_words] => 71975
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202418.pdf
[firstpage_image] =>[orig_patent_app_number] => 11023183
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/023183 | HCV peptide compositions | Dec 27, 2004 | Abandoned |
Array
(
[id] => 488916
[patent_doc_number] => 07214501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-08
[patent_title] => 'Methods of detecting cancer based on osteopontin'
[patent_app_type] => utility
[patent_app_number] => 11/017119
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9220
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/214/07214501.pdf
[firstpage_image] =>[orig_patent_app_number] => 11017119
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/017119 | Methods of detecting cancer based on osteopontin | Dec 20, 2004 | Issued |
Array
(
[id] => 7169439
[patent_doc_number] => 20050202417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Method of detecting and quantifying hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 11/017111
[patent_app_country] => US
[patent_app_date] => 2004-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9896
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202417.pdf
[firstpage_image] =>[orig_patent_app_number] => 11017111
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/017111 | Method of detecting and quantifying hepatitis C virus | Dec 19, 2004 | Abandoned |
Array
(
[id] => 7039408
[patent_doc_number] => 20050158842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Microorganisms and assays for the identification of antibiotics'
[patent_app_type] => utility
[patent_app_number] => 11/011979
[patent_app_country] => US
[patent_app_date] => 2004-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17505
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158842.pdf
[firstpage_image] =>[orig_patent_app_number] => 11011979
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/011979 | Microorganisms and assays for the identification of antibiotics | Dec 12, 2004 | Abandoned |
Array
(
[id] => 6918123
[patent_doc_number] => 20050095684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'G-CSF conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/004461
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 37969
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095684.pdf
[firstpage_image] =>[orig_patent_app_number] => 11004461
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/004461 | G-CSF conjugates | Dec 2, 2004 | Abandoned |
Array
(
[id] => 5590808
[patent_doc_number] => 20060040259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Method for inhibition of viral infection'
[patent_app_type] => utility
[patent_app_number] => 11/000691
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10643
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040259.pdf
[firstpage_image] =>[orig_patent_app_number] => 11000691
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/000691 | Method for inhibition of viral infection | Nov 29, 2004 | Abandoned |